Epidsod 50 features some of our thought provoking past guests of 2025: Kristina Fusella, Lida Citroen, Shannon Keenan, Namita Khatri, Andrea Loewendorf, Gail Tatebe, Tonya Dickenson, Tessa Misiaszek, Jennifer Meehan, Michael Casia,Katy McFee and Litsa Spiridonakos.

In this final podcast of the year, they share their tips on how women and allies can help protect their time, energy and relationships to be even more productive.

Listen to our conversation with Katy McFee, Founder and CEO of Insights to Action Coaching and Consulting. Katy breaks down the importance of shifting from reactivity to proactivity — and how moving beyond constant responsiveness is key to elevating your leadership and driving meaningful impact.

Be sure to listen to the full episode to hear Katy’s insights on over-indexing, gaining visibility, and positioning yourself for real career progression.

About Katy McFee

Katy McFee is a former executive (VP/EVP), Forty Under 40 recipient, and host of the More Women Promoted podcast.

As a certified executive coach, she's helped hundreds of women transition to, and thrive in, senior leadership. Drawing from her own challenging path to the executive suite, Katy is dedicated to closing the gender gap by helping women step into senior roles with confidence and authenticity.

Katy has been featured in Business Insider and has published multiple articles about women and leadership in Forbes.com as a contributor.

For this month’s podcast, we’re joined by Andrea Loewendorf, Head of Immunology Canada at UCB, who explores the transformative role of mentorship and sponsorship in a woman’s leadership journey. She shares how mentorship has shaped her career, and why sponsorship in particular is a catalyst for breaking barriers in pharma.

Tune in as Andrea reflects on the importance of communitynetworks (like WLP), offers practical advice for building meaningful professional relationships, and discusses how women can lift as they lead.

About Andrea Loewendorf

Andrea Loewendorf is an accomplished global leader with over two decades of experience in the biopharma industry. As the Head of Immunology Canada at UCB, she spearheads UCB’s immunology strategy, translating vision into field execution and driving positive impact on patients.

With her extensive background, Andrea has successfullyorchestrated global product launches, consistently prioritizing patient needs and bringing groundbreaking therapies to market. Notably, she set the global commercial strategy for a recent launch and has spent the past six years leading market access teams in the U.S. and across the globe. Her strategic vision extends beyond traditional boundaries, encompassing innovative approaches to market access, digital transformation, and brand excellence.